SCHEMBL31412243

SCHEMBL31412243

Oc1nc(O)c2c(Br)c(F)cc(F)c2n1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31491019 0.84 — —
SCHEMBL30699763 0.81 — —
SCHEMBL31406530 0.80 — —
SCHEMBL31412211 0.78 MAPT (0.38) —
SCHEMBL30699839 0.78 — —
SCHEMBL22029150 0.76 — —
SCHEMBL29937105 0.76 — —
SCHEMBL27053778 0.74 EPRS1 (0.32) —
SCHEMBL27053763 0.74 — —
SCHEMBL24820532 0.73 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119591588-A RAS inhibitors 泰励生物科技(上海)有限公司 2025-03-11 — — CN disclosed
WO-2025049274-A2 TETRACYCLIC DERIVATIVES, COMPOSITIONS AND METHODS THEREOF ENSEM THERAPEUTICS, INC. (US) 2025-03-06 — — WO disclosed
Send feedback